Event Type
Disclosure
Mandatory
Variant
8-K
. Entry into a Material Definitive Agreement On October 20, 2025, Co-Diagnostics, Inc. (the “Company”) entered into an Equity Distribution Agreement (the “Agree
. Termination of a Material Definitive Agreement Effective September 30, 2025, the Company terminated the Amended and Restated Equity Distribution Agreement dat
. Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 5.1 Opinion of Dorsey & Whitney LLP 10.1 Equity Distribution Agreement between Co-Diagn